Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...

Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease ...

Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...

KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...

Fortunately, the scan was negative. With the correct diagnosis in hand, we established that his condition was physiological — not psychological — and treated him with intravenous immunoglobulin and ...

Therefore, it’s important to closely monitor patients after they begin a treatment regimen and adjust accordingly. Oral corticosteroids are anti-inflammatory medications that are the mainstay ...

When you hear that your dog has an infection, you’re most likely thinking of a bacterial or viral infection. However, viruses ...

A young teacher who suffers from severe asthma has spoken of how patients with the high-risk condition can be left on ...

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

[1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR-BHPR guidelines suggesting an initial prednisone dose comprised between 15 and 20 mg as appropriate. [2] However ...

DiffuSphereTM is designed to enable precise drug delivery at therapeutic dose levels directly into target tissues, e ...

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-T) from The Globe and Mail including charting and trades.